Condition: Refractory Status Epilepticus · Sponsor: Xuanwu Hospital, Beijing
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
This description comes directly from the study's public registry record.
research centre of Xuanwu hospital Capital Medical University · +8601083198899 · liugangqingyi@sina.com
Jiaqing Tian, Dr · +8615311415116 · smile21tian@163.com
Always discuss trial participation with your own doctor first.
| Xuanwu Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06344338